Medvest is incorporated by two general partners in the UK with a head office in London and a representative in Tel-Aviv, Israel. Medvest is engaged with funding medical projects, joining professional teams and accompanying entrepreneurs for promising projects into their commercial status or pre-phase III clinical trials. Medvest has four partners and a professional consulting team which has built a strong reputation in recognising, funding, guiding and closing technology deals for projects with capital needs from $100k to $5m.
Medvest is interested in expanding its investment portfolio. By absorbing capital and seeking progressive investors who are interested in being part of a dynamic partnership, with power to fuel innovation and to infuse new energy into the early biotech/medical industry.
By incorporating a hands-on management approach to all portfolio companies, Medvest’s mission is to invest in promising projects, who then develop into valuable ventures.
What We Offer
Establish sourcing channels to stream in a continuous pipeline of excellent projects to enable exclusive constant deal flow. Engage with specialists in the BioMed field to get expert opinions on projects and input on the technology development. Select projects/companies whose investment requirements are typically in three stages, starting with a capital range of $100k and following up to about $1.5m per company.
Advance companies from a short to medium term exit according to a pre-plan business strategy.
Incorporate licensing agreements using companies IP/products based upon a royalty business model.